Home/Products /l-arginine-500mg-micronized-palmitoylethanolamide-4mcg-parsley-extract-50mg-tablet

Monopoly Rights for L-Arginine + PEA Nutraceutical

Name: L-Arginine + PEA + B12 Tablet PCD Franchise
Brand: Argipair P Tablet
Rating: 4.8 (150 reviews)

Target Chronic Pain for High Profit Margins

Argipair P Edge: Dual Action Pain & Blood Flow Support

Secure Exclusive Territory in Neurology/Cardiology Segment

Low Investment, Full Technical Marketing Support

Start Your High-Value Specialty Business Today

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

L-Arginine PEA B12 Franchise in Jaipur Rajasthan

Neuropathy PCD opportunity for Argipair P in Lucknow

Monopoly rights Chronic Pain supplement across Haryana

Specialty pharma franchise opportunity in Ahmedabad

Top PCD business for nutraceuticals in Indore

L-Arginine PEA B12 PCD Franchise Literature PDF

Argipair P Tablet

Composition : L-Arginine (500mg) + Micronized Palmitoylethanolamide (300mg) + Vitamin B12 (2.4mcg) + Parsley Extract (50mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Argipair P Tablet (L-Arginine 500mg + PEA 300mg + B12 + Parsley) is a premium, high-profit product built for our PCD Pharma Franchise partners.

This unique, multi-action formula is essential for managing conditions involving chronic pain, neuropathy, and microcirculation issues (e.g., Diabetic Neuropathy, chronic inflammation). This guarantees strong, persistent prescription demand in a high-value segment.

Why Argipair P is Your Key to Profit:

Unique, High Demand Composition: Combining Palmitoylethanolamide (PEA) for natural pain and inflammation modulation, L-Arginine for improved blood flow, and Vitamin B12 for nerve health, this product is highly rational for doctors and guarantees consistent, high-volume orders.
Specialty Market Margin: Positioned as a specialized nutraceutical, it commands premium pricing and secures some of the highest profit margins within the chronic care segment.
Broad Clinical Utility: Its benefits span Neurology, Diabetology, and General Practice, expanding your target doctor base and building long-term prescription loyalty.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full technical marketing support to convert this high-value product into guaranteed sales growth.

Contact us today to capture this high-margin specialty segment!

About the Product

Argipair P Tablet (L-Arginine 500mg + PEA 300mg + B12 + Parsley) is a premium, high-profit product built for our PCD Pharma Franchise partners.

Why Argipair P is Your Key to Profit:

Unique, High Demand Composition: Combining Palmitoylethanolamide (PEA) for natural pain and inflammation modulation, L-Arginine for improved blood flow, and Vitamin B12 for nerve health, this product is highly rational for doctors and guarantees consistent, high-volume orders.
Specialty Market Margin: Positioned as a specialized nutraceutical, it commands premium pricing and secures some of the highest profit margins within the chronic care segment.
Broad Clinical Utility: Its benefits span Neurology, Diabetology, and General Practice, expanding your target doctor base and building long-term prescription loyalty.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated territory. Partner with us for full technical marketing support to convert this high-value product into guaranteed sales growth.

Contact us today to capture this high-margin specialty segment!

Patients may experience injection site discomfort, gastrointestinal upset (nausea, vomiting, diarrhea), rash, or mild liver enzyme elevations. Less commonly, hypersensitivity reactions and hematologic abnormalities such as eosinophilia or neutropenia may occur. Rare instances of C. difficile-associated diarrhea should be considered during prolonged use.

This formulation is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections (including pneumonia), intra-abdominal infections, skin and soft tissue infections, gynecological infections, and septicemia caused by susceptible gram-negative bacteria. It is particularly valuable in hospital-acquired infections or polymicrobial infections when used in combination with other antimicrobials.

This injection should only be used under the supervision of a qualified healthcare professional. Renal function should be monitored in long-term or high-dose treatments, and dose adjustment may be required in renal impairment. Aztreonam is not effective against gram-positive or anaerobic organisms, and should be used in combination therapy if mixed infections are suspected.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.